Diversified Trust’s Lifecore Biomedical LFCR Stock Holding History

Diversified Trust’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$95.3K	Hold	18,146	–	–	﹤0.01%	1077
2026 Q1	$67.5K	Hold	18,146	–	–	﹤0.01%	1020
2025 Q4	$148K	Hold	18,146	–	–	﹤0.01%	994
2025 Q3	$134K	Sell	18,146 -27,916	-61%	-$211K	﹤0.01%	958
2025 Q2	$374K	Hold	46,062	–	–	0.01%	685
2025 Q1	$324K	Hold	46,062	–	–	0.01%	710
2024 Q4	$342K	Sell	46,062 -59	-0.1%	-$377	0.01%	713
2024 Q3	$227K	Buy	46,121 +59	+0.1%	+$308	0.01%	812
2024 Q2	$236K	Hold	46,062	–	–	0.01%	743
2024 Q1	$245K	Hold	46,062	–	–	0.01%	702
2023 Q4	$285K	Hold	46,062	–	–	0.01%	677
2023 Q3	$348K	Hold	46,062	–	–	0.01%	572
2023 Q2	$445K	Hold	46,062	–	–	0.02%	507
2023 Q1	$174K	Hold	46,062	–	–	0.01%	764
2022 Q4	$298K	Buy	46,062 +9,474	+26%	+$78.1K	0.01%	589
2022 Q3	$325K	Hold	36,588	–	–	0.01%	517
2022 Q2	$365K	Buy	36,588 +7,059	+24%	+$69.9K	0.02%	508
2022 Q1	$342K	Hold	29,529	–	–	0.01%	571
2021 Q4	$328K	Buy	+29,529	New	+$287K	0.01%	608

Other funds holding LFCR

Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Diversified Trust's LFCR Position: Q2 2026 in Review

Diversified Trust held its Lifecore Biomedical (LFCR) position steady in Q2 2026 at 18,146 shares worth $95.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1077.

Diversified Trust first reported a position in LFCR in Q4 2021 and has held it in 19 quarters since. The position peaked at $445K in Q2 2023. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

Diversified Trust held 18,146 shares of Lifecore Biomedical worth $95.3K as of Q2 2026.
Diversified Trust left its Lifecore Biomedical share count unchanged in Q2 2026.
Lifecore Biomedical made up ﹤0.01% of Diversified Trust's portfolio in Q2 2026, its #1077 holding.
Diversified Trust first reported a position in Lifecore Biomedical in Q4 2021 and has held it in 19 quarters since.
Diversified Trust's Lifecore Biomedical position peaked at $445K in Q2 2023.
99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.